Dynavax Technologies (DVAX) EBT (2016 - 2025)
Historic EBT for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to $28.4 million.
- Dynavax Technologies' EBT rose 4339.99% to $28.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$40.6 million, marking a year-over-year decrease of 26765.47%. This contributed to the annual value of $30.9 million for FY2024, which is 80654.91% up from last year.
- Latest data reveals that Dynavax Technologies reported EBT of $28.4 million as of Q3 2025, which was up 4339.99% from $21.2 million recorded in Q2 2025.
- In the past 5 years, Dynavax Technologies' EBT registered a high of $129.4 million during Q2 2022, and its lowest value of -$97.9 million during Q1 2025.
- Over the past 5 years, Dynavax Technologies' median EBT value was $14.9 million (recorded in 2024), while the average stood at $19.6 million.
- As far as peak fluctuations go, Dynavax Technologies' EBT soared by 279233.18% in 2022, and later crashed by 75130.9% in 2025.
- Dynavax Technologies' EBT (Quarter) stood at $100.6 million in 2021, then crashed by 32.42% to $68.0 million in 2022, then crashed by 98.53% to $996000.0 in 2023, then surged by 665.96% to $7.6 million in 2024, then surged by 272.51% to $28.4 million in 2025.
- Its EBT was $28.4 million in Q3 2025, compared to $21.2 million in Q2 2025 and -$97.9 million in Q1 2025.